Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
IRF2
|
ENSG00000168310.6 | interferon regulatory factor 2 |
STAT2
|
ENSG00000170581.9 | signal transducer and activator of transcription 2 |
IRF8
|
ENSG00000140968.6 | interferon regulatory factor 8 |
IRF1
|
ENSG00000125347.9 | interferon regulatory factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRF2 | hg19_v2_chr4_-_185395672_185395734 | 0.61 | 1.1e-03 | Click! |
IRF8 | hg19_v2_chr16_+_85942594_85942635 | 0.56 | 3.6e-03 | Click! |
IRF1 | hg19_v2_chr5_-_131826457_131826514 | 0.48 | 1.6e-02 | Click! |
STAT2 | hg19_v2_chr12_-_56753858_56753930 | 0.15 | 4.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_79086088 | 164.59 |
ENST00000370751.5
ENST00000342282.3 |
IFI44L
|
interferon-induced protein 44-like |
chr4_-_76944621 | 144.04 |
ENST00000306602.1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10 |
chr6_+_32821924 | 132.47 |
ENST00000374859.2
ENST00000453265.2 |
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr13_-_43566301 | 121.83 |
ENST00000398762.3
ENST00000313640.7 ENST00000313624.7 |
EPSTI1
|
epithelial stromal interaction 1 (breast) |
chr2_-_7005785 | 116.38 |
ENST00000256722.5
ENST00000404168.1 ENST00000458098.1 |
CMPK2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
chr10_+_91092241 | 115.18 |
ENST00000371811.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr10_+_91087651 | 112.71 |
ENST00000371818.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr21_+_42792442 | 105.80 |
ENST00000398600.2
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr10_+_91152303 | 105.39 |
ENST00000371804.3
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr17_-_40264692 | 93.08 |
ENST00000591220.1
ENST00000251642.3 |
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr12_+_113376157 | 84.88 |
ENST00000228928.7
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr6_-_32821599 | 84.37 |
ENST00000354258.4
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr17_+_6659153 | 82.43 |
ENST00000441631.1
ENST00000438512.1 ENST00000346752.4 ENST00000361842.3 |
XAF1
|
XIAP associated factor 1 |
chr6_-_29527702 | 82.13 |
ENST00000377050.4
|
UBD
|
ubiquitin D |
chr22_+_18632666 | 81.07 |
ENST00000215794.7
|
USP18
|
ubiquitin specific peptidase 18 |
chr12_+_113416191 | 79.64 |
ENST00000342315.4
ENST00000392583.2 |
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr3_+_122399444 | 78.26 |
ENST00000474629.2
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14 |
chr10_+_91174314 | 75.46 |
ENST00000371795.4
|
IFIT5
|
interferon-induced protein with tetratricopeptide repeats 5 |
chr16_-_67970990 | 72.94 |
ENST00000358514.4
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
chr3_-_122283424 | 71.07 |
ENST00000477522.2
ENST00000360356.2 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr3_-_122283079 | 70.31 |
ENST00000471785.1
ENST00000466126.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr1_-_89488510 | 66.67 |
ENST00000564665.1
ENST00000370481.4 |
GBP3
|
guanylate binding protein 3 |
chr11_-_4414880 | 62.59 |
ENST00000254436.7
ENST00000543625.1 |
TRIM21
|
tripartite motif containing 21 |
chr3_+_122283064 | 61.98 |
ENST00000296161.4
|
DTX3L
|
deltex 3-like (Drosophila) |
chr9_+_5510492 | 61.33 |
ENST00000397745.2
|
PDCD1LG2
|
programmed cell death 1 ligand 2 |
chr9_-_32526184 | 60.47 |
ENST00000545044.1
ENST00000379868.1 |
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr9_+_5510558 | 60.35 |
ENST00000397747.3
|
PDCD1LG2
|
programmed cell death 1 ligand 2 |
chr1_-_89531041 | 59.97 |
ENST00000370473.4
|
GBP1
|
guanylate binding protein 1, interferon-inducible |
chr6_+_26440700 | 59.29 |
ENST00000494393.1
ENST00000482451.1 ENST00000244519.2 ENST00000339789.4 ENST00000471353.1 ENST00000361232.3 ENST00000487627.1 ENST00000496719.1 ENST00000490254.1 ENST00000487272.1 |
BTN3A3
|
butyrophilin, subfamily 3, member A3 |
chr16_+_57023406 | 59.11 |
ENST00000262510.6
ENST00000308149.7 ENST00000436936.1 |
NLRC5
|
NLR family, CARD domain containing 5 |
chr4_-_169239921 | 56.91 |
ENST00000514995.1
ENST00000393743.3 |
DDX60
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
chr7_-_92777606 | 55.89 |
ENST00000437805.1
ENST00000446959.1 ENST00000439952.1 ENST00000414791.1 ENST00000446033.1 ENST00000411955.1 ENST00000318238.4 |
SAMD9L
|
sterile alpha motif domain containing 9-like |
chr15_+_89182156 | 55.71 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr15_+_89182178 | 55.40 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr4_+_142557717 | 51.47 |
ENST00000320650.4
ENST00000296545.7 |
IL15
|
interleukin 15 |
chr2_+_7017796 | 50.48 |
ENST00000382040.3
|
RSAD2
|
radical S-adenosyl methionine domain containing 2 |
chr1_+_79115503 | 49.08 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
chr11_-_60719213 | 48.83 |
ENST00000227880.3
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr15_+_89181974 | 48.20 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr22_-_36556821 | 46.74 |
ENST00000531095.1
ENST00000397293.2 ENST00000349314.2 |
APOL3
|
apolipoprotein L, 3 |
chr11_-_615942 | 46.68 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
chr4_+_142557771 | 45.99 |
ENST00000514653.1
|
IL15
|
interleukin 15 |
chr6_-_32806506 | 45.31 |
ENST00000374897.2
ENST00000452392.2 |
TAP2
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Uncharacterized protein |
chr12_+_113376249 | 44.02 |
ENST00000551007.1
ENST00000548514.1 |
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr21_+_42798094 | 43.80 |
ENST00000398598.3
ENST00000455164.2 ENST00000424365.1 |
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr6_+_32811885 | 42.03 |
ENST00000458296.1
ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1
PSMB9
|
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
chr12_+_113344755 | 41.32 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr3_-_122283100 | 41.12 |
ENST00000492382.1
ENST00000462315.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr19_+_10196781 | 40.84 |
ENST00000253110.11
|
C19orf66
|
chromosome 19 open reading frame 66 |
chr12_+_113344811 | 40.78 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr4_+_142558078 | 40.74 |
ENST00000529613.1
|
IL15
|
interleukin 15 |
chr1_+_948803 | 39.87 |
ENST00000379389.4
|
ISG15
|
ISG15 ubiquitin-like modifier |
chr11_-_57335280 | 39.58 |
ENST00000287156.4
|
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6 |
chr9_-_100881466 | 39.06 |
ENST00000341469.2
ENST00000342043.3 ENST00000375098.3 |
TRIM14
|
tripartite motif containing 14 |
chr2_-_231084820 | 38.38 |
ENST00000258382.5
ENST00000338556.3 |
SP110
|
SP110 nuclear body protein |
chr2_-_163175133 | 38.35 |
ENST00000421365.2
ENST00000263642.2 |
IFIH1
|
interferon induced with helicase C domain 1 |
chr11_+_69455855 | 36.87 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr14_+_94577074 | 36.20 |
ENST00000444961.1
ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27
|
interferon, alpha-inducible protein 27 |
chr15_-_80263506 | 34.43 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr11_-_615570 | 34.35 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr19_+_10196981 | 33.06 |
ENST00000591813.1
|
C19orf66
|
chromosome 19 open reading frame 66 |
chr21_+_42733870 | 32.94 |
ENST00000330714.3
ENST00000436410.1 ENST00000435611.1 |
MX2
|
myxovirus (influenza virus) resistance 2 (mouse) |
chr13_+_50070491 | 32.32 |
ENST00000496612.1
ENST00000357596.3 ENST00000485919.1 ENST00000442195.1 |
PHF11
|
PHD finger protein 11 |
chr11_+_71710973 | 32.09 |
ENST00000393707.4
|
IL18BP
|
interleukin 18 binding protein |
chr22_+_36044411 | 31.79 |
ENST00000409652.4
|
APOL6
|
apolipoprotein L, 6 |
chr6_+_26402465 | 31.22 |
ENST00000476549.2
ENST00000289361.6 ENST00000450085.2 ENST00000425234.2 ENST00000427334.1 ENST00000506698.1 |
BTN3A1
|
butyrophilin, subfamily 3, member A1 |
chr19_+_18284477 | 31.19 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr11_+_71709938 | 31.10 |
ENST00000393705.4
ENST00000337131.5 ENST00000531053.1 ENST00000404792.1 |
IL18BP
|
interleukin 18 binding protein |
chr13_+_50070077 | 30.99 |
ENST00000378319.3
ENST00000426879.1 |
PHF11
|
PHD finger protein 11 |
chr11_+_71710648 | 30.26 |
ENST00000260049.5
|
IL18BP
|
interleukin 18 binding protein |
chr19_-_50400212 | 29.49 |
ENST00000391826.2
|
IL4I1
|
interleukin 4 induced 1 |
chr1_-_173020056 | 29.44 |
ENST00000239468.2
ENST00000404377.3 |
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18 |
chr12_+_102271129 | 29.44 |
ENST00000258534.8
|
DRAM1
|
DNA-damage regulated autophagy modulator 1 |
chr9_+_100174232 | 29.43 |
ENST00000355295.4
|
TDRD7
|
tudor domain containing 7 |
chr8_-_23540402 | 29.34 |
ENST00000523261.1
ENST00000380871.4 |
NKX3-1
|
NK3 homeobox 1 |
chr6_+_26365443 | 29.25 |
ENST00000527422.1
ENST00000356386.2 ENST00000396934.3 ENST00000377708.2 ENST00000396948.1 ENST00000508906.2 |
BTN3A2
|
butyrophilin, subfamily 3, member A2 |
chr9_+_100174344 | 29.00 |
ENST00000422139.2
|
TDRD7
|
tudor domain containing 7 |
chr12_+_113416265 | 28.83 |
ENST00000449768.2
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr10_+_115439282 | 28.14 |
ENST00000369321.2
ENST00000345633.4 |
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
chr10_+_115439699 | 27.51 |
ENST00000369315.1
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
chr12_+_113344582 | 27.27 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr6_+_126240442 | 27.19 |
ENST00000448104.1
ENST00000438495.1 ENST00000444128.1 |
NCOA7
|
nuclear receptor coactivator 7 |
chr11_-_104905840 | 27.18 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr1_+_110453203 | 27.16 |
ENST00000357302.4
ENST00000344188.5 ENST00000329608.6 |
CSF1
|
colony stimulating factor 1 (macrophage) |
chr10_+_115439630 | 26.95 |
ENST00000369318.3
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
chr22_+_36649056 | 26.83 |
ENST00000397278.3
ENST00000422706.1 ENST00000426053.1 ENST00000319136.4 |
APOL1
|
apolipoprotein L, 1 |
chr2_+_102972363 | 26.75 |
ENST00000409599.1
|
IL18R1
|
interleukin 18 receptor 1 |
chr17_+_18380051 | 26.65 |
ENST00000581545.1
ENST00000582333.1 ENST00000328114.6 ENST00000412421.2 ENST00000583322.1 ENST00000584941.1 |
LGALS9C
|
lectin, galactoside-binding, soluble, 9C |
chr17_+_25958174 | 26.45 |
ENST00000313648.6
ENST00000577392.1 ENST00000584661.1 ENST00000413914.2 |
LGALS9
|
lectin, galactoside-binding, soluble, 9 |
chr15_+_74287009 | 26.25 |
ENST00000395135.3
|
PML
|
promyelocytic leukemia |
chr3_+_187086120 | 25.91 |
ENST00000259030.2
|
RTP4
|
receptor (chemosensory) transporter protein 4 |
chr7_+_100728720 | 25.85 |
ENST00000306085.6
ENST00000412507.1 |
TRIM56
|
tripartite motif containing 56 |
chr2_-_220252603 | 25.83 |
ENST00000322176.7
ENST00000273075.4 |
DNPEP
|
aspartyl aminopeptidase |
chr2_-_231084617 | 25.82 |
ENST00000409815.2
|
SP110
|
SP110 nuclear body protein |
chr20_-_47894569 | 25.37 |
ENST00000371744.1
ENST00000371752.1 ENST00000396105.1 |
ZNFX1
|
zinc finger, NFX1-type containing 1 |
chr15_+_74287035 | 25.37 |
ENST00000395132.2
ENST00000268059.6 ENST00000354026.6 ENST00000268058.3 ENST00000565898.1 ENST00000569477.1 ENST00000569965.1 ENST00000567543.1 ENST00000436891.3 ENST00000435786.2 ENST00000564428.1 ENST00000359928.4 |
PML
|
promyelocytic leukemia |
chr14_+_24630465 | 25.23 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr22_+_39436862 | 25.10 |
ENST00000381565.2
ENST00000452957.2 |
APOBEC3F
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G |
chr9_-_32526299 | 25.06 |
ENST00000379882.1
ENST00000379883.2 |
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr6_-_32811771 | 24.64 |
ENST00000395339.3
ENST00000374882.3 |
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 |
chr1_+_110453608 | 24.43 |
ENST00000369801.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
chr11_+_5710919 | 23.79 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr15_+_74287118 | 23.35 |
ENST00000563500.1
|
PML
|
promyelocytic leukemia |
chr2_+_201981527 | 23.34 |
ENST00000441224.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr1_+_110453109 | 23.24 |
ENST00000525659.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
chr2_-_231084659 | 23.24 |
ENST00000258381.6
ENST00000358662.4 ENST00000455674.1 ENST00000392048.3 |
SP110
|
SP110 nuclear body protein |
chr10_+_91061712 | 22.04 |
ENST00000371826.3
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2 |
chr6_-_33282163 | 21.23 |
ENST00000434618.2
ENST00000456592.2 |
TAPBP
|
TAP binding protein (tapasin) |
chr6_+_32811861 | 21.09 |
ENST00000453426.1
|
TAPSAR1
|
TAP1 and PSMB8 antisense RNA 1 |
chr4_-_169401628 | 20.69 |
ENST00000514748.1
ENST00000512371.1 ENST00000260184.7 ENST00000505890.1 ENST00000511577.1 |
DDX60L
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like |
chr7_+_18535786 | 20.69 |
ENST00000406072.1
|
HDAC9
|
histone deacetylase 9 |
chr2_+_231280908 | 19.43 |
ENST00000427101.2
ENST00000432979.1 |
SP100
|
SP100 nuclear antigen |
chr11_+_93861993 | 19.40 |
ENST00000227638.3
ENST00000436171.2 |
PANX1
|
pannexin 1 |
chr1_+_110453462 | 18.86 |
ENST00000488198.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
chr5_+_96212185 | 18.45 |
ENST00000379904.4
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr5_-_96143796 | 18.38 |
ENST00000296754.3
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1 |
chr6_+_127439749 | 18.08 |
ENST00000356698.4
|
RSPO3
|
R-spondin 3 |
chr5_+_96211643 | 17.94 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr1_-_154580616 | 17.80 |
ENST00000368474.4
|
ADAR
|
adenosine deaminase, RNA-specific |
chr21_+_43619796 | 17.48 |
ENST00000398457.2
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
chr17_+_41363854 | 17.35 |
ENST00000588693.1
ENST00000588659.1 ENST00000541594.1 ENST00000536052.1 ENST00000331615.3 |
TMEM106A
|
transmembrane protein 106A |
chr22_-_36635684 | 17.25 |
ENST00000358502.5
|
APOL2
|
apolipoprotein L, 2 |
chr17_+_41158742 | 16.99 |
ENST00000415816.2
ENST00000438323.2 |
IFI35
|
interferon-induced protein 35 |
chr5_-_96143602 | 16.96 |
ENST00000443439.2
ENST00000503921.1 ENST00000508227.1 ENST00000507154.1 |
ERAP1
|
endoplasmic reticulum aminopeptidase 1 |
chr2_+_231280954 | 16.91 |
ENST00000409824.1
ENST00000409341.1 ENST00000409112.1 ENST00000340126.4 ENST00000341950.4 |
SP100
|
SP100 nuclear antigen |
chr4_+_186990298 | 16.78 |
ENST00000296795.3
ENST00000513189.1 |
TLR3
|
toll-like receptor 3 |
chr22_+_41697520 | 16.50 |
ENST00000352645.4
|
ZC3H7B
|
zinc finger CCCH-type containing 7B |
chr1_+_165864800 | 16.11 |
ENST00000469256.2
|
UCK2
|
uridine-cytidine kinase 2 |
chr1_+_165864821 | 16.10 |
ENST00000470820.1
|
UCK2
|
uridine-cytidine kinase 2 |
chr14_+_58711539 | 15.93 |
ENST00000216455.4
ENST00000412908.2 ENST00000557508.1 |
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3 |
chr17_-_20370847 | 15.69 |
ENST00000423676.3
ENST00000324290.5 |
LGALS9B
|
lectin, galactoside-binding, soluble, 9B |
chr4_+_37892682 | 15.65 |
ENST00000508802.1
ENST00000261439.4 ENST00000402522.1 |
TBC1D1
|
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
chr4_-_185395672 | 15.51 |
ENST00000393593.3
|
IRF2
|
interferon regulatory factor 2 |
chr20_+_388935 | 15.42 |
ENST00000382181.2
ENST00000400247.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr1_-_150738261 | 15.17 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr20_+_388679 | 14.95 |
ENST00000356286.5
ENST00000475269.1 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr11_-_64764435 | 14.90 |
ENST00000534177.1
ENST00000301887.4 |
BATF2
|
basic leucine zipper transcription factor, ATF-like 2 |
chr21_+_43933946 | 14.81 |
ENST00000352133.2
|
SLC37A1
|
solute carrier family 37 (glucose-6-phosphate transporter), member 1 |
chr6_+_26402517 | 14.63 |
ENST00000414912.2
|
BTN3A1
|
butyrophilin, subfamily 3, member A1 |
chr6_-_31324943 | 14.58 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr6_+_116782527 | 14.03 |
ENST00000368606.3
ENST00000368605.1 |
FAM26F
|
family with sequence similarity 26, member F |
chr2_-_152146385 | 13.83 |
ENST00000414946.1
ENST00000243346.5 |
NMI
|
N-myc (and STAT) interactor |
chr3_+_48507210 | 13.72 |
ENST00000433541.1
ENST00000422277.2 ENST00000436480.2 ENST00000444177.1 |
TREX1
|
three prime repair exonuclease 1 |
chr1_-_149908710 | 13.71 |
ENST00000439741.2
ENST00000361405.6 ENST00000406732.3 |
MTMR11
|
myotubularin related protein 11 |
chr20_+_61436146 | 13.67 |
ENST00000290291.6
|
OGFR
|
opioid growth factor receptor |
chr6_-_87804815 | 13.54 |
ENST00000369582.2
|
CGA
|
glycoprotein hormones, alpha polypeptide |
chr11_-_104972158 | 13.47 |
ENST00000598974.1
ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1
CARD16
CARD17
|
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
chr5_+_125695805 | 13.40 |
ENST00000513040.1
|
GRAMD3
|
GRAM domain containing 3 |
chr2_+_231191875 | 13.34 |
ENST00000444636.1
ENST00000415673.2 ENST00000243810.6 ENST00000396563.4 |
SP140L
|
SP140 nuclear body protein-like |
chr1_+_113217345 | 13.33 |
ENST00000357443.2
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
chr12_+_6561190 | 13.16 |
ENST00000544021.1
ENST00000266556.7 |
TAPBPL
|
TAP binding protein-like |
chr1_+_113217309 | 13.10 |
ENST00000544796.1
ENST00000369644.1 |
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
chr17_-_4167142 | 13.04 |
ENST00000570535.1
ENST00000574367.1 ENST00000341657.4 ENST00000433651.1 |
ANKFY1
|
ankyrin repeat and FYVE domain containing 1 |
chr1_+_113217043 | 13.00 |
ENST00000413052.2
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
chr5_+_118690466 | 12.69 |
ENST00000503646.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr9_+_74764278 | 12.64 |
ENST00000238018.4
ENST00000376989.3 |
GDA
|
guanine deaminase |
chr1_+_113217073 | 12.53 |
ENST00000369645.1
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
chr6_-_33282024 | 12.39 |
ENST00000475304.1
ENST00000489157.1 |
TAPBP
|
TAP binding protein (tapasin) |
chr7_-_77045617 | 12.21 |
ENST00000257626.7
|
GSAP
|
gamma-secretase activating protein |
chr17_-_4643114 | 12.20 |
ENST00000293778.6
|
CXCL16
|
chemokine (C-X-C motif) ligand 16 |
chr20_+_53092123 | 11.90 |
ENST00000262593.5
|
DOK5
|
docking protein 5 |
chr17_+_78234625 | 11.83 |
ENST00000508628.2
ENST00000582970.1 ENST00000456466.1 ENST00000319921.4 |
RNF213
|
ring finger protein 213 |
chr3_-_123339343 | 11.68 |
ENST00000578202.1
|
MYLK
|
myosin light chain kinase |
chr3_-_123339418 | 11.62 |
ENST00000583087.1
|
MYLK
|
myosin light chain kinase |
chr2_-_231989808 | 11.52 |
ENST00000258400.3
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
chr7_+_4815238 | 11.34 |
ENST00000348624.4
ENST00000401897.1 |
AP5Z1
|
adaptor-related protein complex 5, zeta 1 subunit |
chr1_-_173176452 | 11.19 |
ENST00000281834.3
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4 |
chr2_+_201994208 | 11.16 |
ENST00000440180.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr6_-_82462425 | 11.15 |
ENST00000369754.3
ENST00000320172.6 ENST00000369756.3 |
FAM46A
|
family with sequence similarity 46, member A |
chr14_-_24615523 | 10.96 |
ENST00000559056.1
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr14_-_24615805 | 10.83 |
ENST00000560410.1
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr14_+_24605389 | 10.82 |
ENST00000382708.3
ENST00000561435.1 |
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr6_+_153552455 | 10.81 |
ENST00000392385.2
|
AL590867.1
|
Uncharacterized protein; cDNA FLJ59044, highly similar to LINE-1 reverse transcriptase homolog |
chr10_+_24497704 | 10.80 |
ENST00000376456.4
ENST00000458595.1 |
KIAA1217
|
KIAA1217 |
chr16_+_50776021 | 10.70 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr14_+_24605361 | 10.68 |
ENST00000206451.6
ENST00000559123.1 |
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr4_+_154622652 | 10.51 |
ENST00000260010.6
|
TLR2
|
toll-like receptor 2 |
chr9_+_116917807 | 10.47 |
ENST00000356083.3
|
COL27A1
|
collagen, type XXVII, alpha 1 |
chr7_-_92747269 | 10.41 |
ENST00000446617.1
ENST00000379958.2 |
SAMD9
|
sterile alpha motif domain containing 9 |
chr17_+_7358889 | 10.21 |
ENST00000575379.1
|
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle) |
chr7_+_18535346 | 10.18 |
ENST00000405010.3
ENST00000406451.4 ENST00000428307.2 |
HDAC9
|
histone deacetylase 9 |
chr19_-_49371711 | 10.16 |
ENST00000355496.5
ENST00000263265.6 |
PLEKHA4
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 |
chr8_-_145060593 | 10.15 |
ENST00000313059.5
ENST00000524918.1 ENST00000313028.7 ENST00000525773.1 |
PARP10
|
poly (ADP-ribose) polymerase family, member 10 |
chr6_-_30181133 | 10.14 |
ENST00000454678.2
ENST00000434785.1 |
TRIM26
|
tripartite motif containing 26 |
chr17_-_34207295 | 10.03 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr3_+_48507621 | 9.98 |
ENST00000456089.1
|
TREX1
|
three prime repair exonuclease 1 |
chr2_+_201994569 | 9.95 |
ENST00000457277.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr20_+_388791 | 9.78 |
ENST00000441733.1
ENST00000353660.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr1_-_27998689 | 9.74 |
ENST00000339145.4
ENST00000362020.4 ENST00000361157.6 |
IFI6
|
interferon, alpha-inducible protein 6 |
chr2_-_55920952 | 9.54 |
ENST00000447944.2
|
PNPT1
|
polyribonucleotide nucleotidyltransferase 1 |
chr6_-_30181156 | 9.35 |
ENST00000418026.1
ENST00000416596.1 ENST00000453195.1 |
TRIM26
|
tripartite motif containing 26 |
chr7_+_134551583 | 9.29 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chr20_+_44746939 | 9.27 |
ENST00000372276.3
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5 |
chr5_+_49962495 | 9.26 |
ENST00000515175.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr19_-_4338838 | 9.25 |
ENST00000594605.1
|
STAP2
|
signal transducing adaptor family member 2 |
chr19_-_47735918 | 9.05 |
ENST00000449228.1
ENST00000300880.7 ENST00000341983.4 |
BBC3
|
BCL2 binding component 3 |
chr15_+_67418047 | 8.93 |
ENST00000540846.2
|
SMAD3
|
SMAD family member 3 |
chr1_+_110453514 | 8.90 |
ENST00000369802.3
ENST00000420111.2 |
CSF1
|
colony stimulating factor 1 (macrophage) |
chr16_+_50775971 | 8.70 |
ENST00000311559.9
ENST00000564326.1 ENST00000566206.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr6_-_33281979 | 8.57 |
ENST00000426633.2
ENST00000467025.1 |
TAPBP
|
TAP binding protein (tapasin) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
46.1 | 138.2 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
38.8 | 116.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
37.4 | 149.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
35.2 | 140.7 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
35.1 | 105.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
31.9 | 159.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
30.9 | 123.5 | GO:0046967 | cytosol to ER transport(GO:0046967) |
20.5 | 102.6 | GO:0060611 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
20.4 | 204.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
19.2 | 249.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
18.2 | 200.5 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
18.2 | 91.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
16.6 | 182.5 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
16.4 | 82.1 | GO:0070842 | aggresome assembly(GO:0070842) |
15.6 | 62.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
15.0 | 60.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
14.1 | 42.2 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
13.6 | 108.5 | GO:0018377 | protein myristoylation(GO:0018377) |
13.2 | 131.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
13.2 | 13.2 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
13.1 | 130.7 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
12.6 | 62.9 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
10.3 | 82.6 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
10.1 | 50.5 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
9.2 | 27.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
9.1 | 36.3 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
8.8 | 26.4 | GO:0002519 | natural killer cell tolerance induction(GO:0002519) regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
8.1 | 32.2 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
7.4 | 29.4 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
7.0 | 69.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
6.7 | 46.7 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
6.6 | 99.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
6.6 | 79.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
5.9 | 17.8 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
5.0 | 40.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
4.9 | 29.3 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
4.7 | 52.0 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
4.6 | 13.8 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
4.4 | 17.5 | GO:0009726 | detection of endogenous stimulus(GO:0009726) response to high density lipoprotein particle(GO:0055099) |
4.2 | 25.1 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
4.2 | 16.7 | GO:0033590 | response to cobalamin(GO:0033590) |
3.8 | 41.5 | GO:0070141 | response to UV-A(GO:0070141) |
3.7 | 11.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
3.6 | 32.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
3.5 | 7.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
3.5 | 10.5 | GO:0070340 | central nervous system myelin formation(GO:0032289) regulation of interleukin-18 production(GO:0032661) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
3.4 | 75.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
3.4 | 94.3 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
3.3 | 16.3 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
3.2 | 330.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
3.2 | 9.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
2.9 | 11.8 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
2.9 | 26.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.9 | 281.2 | GO:0034340 | response to type I interferon(GO:0034340) |
2.7 | 5.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
2.7 | 13.5 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
2.7 | 23.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.6 | 7.9 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
2.6 | 7.7 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
2.4 | 12.2 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
2.4 | 26.7 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
2.4 | 7.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
2.4 | 11.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
2.3 | 6.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.2 | 8.8 | GO:0003409 | optic cup structural organization(GO:0003409) |
2.2 | 6.6 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
2.2 | 6.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
2.2 | 6.5 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
2.1 | 8.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
2.1 | 60.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
2.0 | 14.3 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
2.0 | 8.0 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
2.0 | 29.5 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.9 | 19.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
1.8 | 5.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) response to biotin(GO:0070781) |
1.8 | 59.7 | GO:0010390 | histone monoubiquitination(GO:0010390) |
1.8 | 7.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.7 | 5.2 | GO:0070541 | response to platinum ion(GO:0070541) |
1.7 | 6.7 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
1.6 | 1.6 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
1.6 | 6.2 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
1.6 | 12.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.5 | 4.6 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
1.5 | 18.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.5 | 10.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.5 | 8.9 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
1.4 | 7.2 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
1.4 | 27.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.4 | 4.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.4 | 5.4 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
1.3 | 5.2 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
1.3 | 2.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.3 | 3.9 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
1.3 | 1.3 | GO:0051595 | response to methylglyoxal(GO:0051595) |
1.3 | 34.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.3 | 39.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.3 | 3.8 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
1.2 | 6.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.1 | 7.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.1 | 2.1 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
1.0 | 5.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
1.0 | 5.1 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
1.0 | 6.0 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
1.0 | 13.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.0 | 13.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
1.0 | 6.8 | GO:0080009 | mRNA methylation(GO:0080009) |
1.0 | 3.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.9 | 230.1 | GO:0051607 | defense response to virus(GO:0051607) |
0.9 | 2.8 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.9 | 10.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.9 | 1.8 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.9 | 5.5 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.9 | 13.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.9 | 4.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.9 | 7.9 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.9 | 12.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.9 | 5.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.9 | 2.6 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.9 | 6.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.9 | 6.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.9 | 3.4 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.8 | 6.8 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.8 | 5.9 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.8 | 3.4 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.8 | 2.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.8 | 1.6 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.8 | 13.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.8 | 3.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.8 | 14.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.8 | 4.6 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.8 | 12.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.7 | 3.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.7 | 4.7 | GO:0035799 | ureter maturation(GO:0035799) |
0.7 | 10.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.7 | 15.9 | GO:0043011 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
0.7 | 6.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.6 | 2.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 3.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.6 | 1.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.6 | 3.1 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.6 | 16.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.6 | 1.8 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.6 | 0.6 | GO:0015747 | urate transport(GO:0015747) |
0.6 | 0.6 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.6 | 8.5 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.6 | 50.6 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.6 | 8.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.6 | 3.3 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.6 | 7.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 7.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.5 | 2.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.5 | 1.6 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.5 | 6.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.5 | 3.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.5 | 2.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 1.4 | GO:0051598 | meiotic DNA double-strand break formation(GO:0042138) meiotic recombination checkpoint(GO:0051598) |
0.5 | 1.9 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.5 | 0.9 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 7.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.5 | 4.2 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.5 | 1.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.5 | 20.7 | GO:0019835 | cytolysis(GO:0019835) |
0.5 | 1.4 | GO:1902871 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.5 | 4.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 5.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 1.7 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.4 | 2.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.4 | 6.3 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 2.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.4 | 0.4 | GO:1902869 | regulation of neural retina development(GO:0061074) regulation of amacrine cell differentiation(GO:1902869) |
0.4 | 1.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.4 | 0.8 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.4 | 4.3 | GO:0060013 | righting reflex(GO:0060013) |
0.4 | 2.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.4 | 1.1 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.4 | 1.1 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.4 | 2.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.4 | 8.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.4 | 4.3 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.4 | 5.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 1.8 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.4 | 1.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.4 | 88.0 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.4 | 2.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 1.7 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.3 | 8.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 5.8 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 1.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.3 | 2.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 2.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.3 | 1.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 3.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.3 | 1.0 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.3 | 3.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 2.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 3.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 0.9 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
0.3 | 0.9 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 0.9 | GO:0048627 | myoblast development(GO:0048627) |
0.3 | 4.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 0.6 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.3 | 1.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.3 | 12.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 6.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.3 | 2.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 1.4 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.3 | 7.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 1.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 8.1 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
0.3 | 1.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 7.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.3 | 4.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 3.6 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.3 | 1.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 1.0 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.3 | 2.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 17.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 13.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 7.8 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.2 | 3.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 1.0 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.5 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 26.1 | GO:0009615 | response to virus(GO:0009615) |
0.2 | 2.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 2.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 11.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 1.3 | GO:0021678 | third ventricle development(GO:0021678) |
0.2 | 7.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 2.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 1.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 9.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.2 | 4.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 1.9 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 1.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 40.8 | GO:0015992 | proton transport(GO:0015992) |
0.2 | 0.6 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.2 | 1.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.4 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 1.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.2 | 1.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 2.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.2 | 0.5 | GO:0033685 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 1.0 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.2 | 2.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.7 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.2 | 2.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 4.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 2.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 4.1 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.2 | 0.5 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.2 | 1.2 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 0.6 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 4.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 4.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 1.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 1.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 2.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 1.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 1.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 4.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.5 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 1.8 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 1.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.4 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 2.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.5 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 3.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.1 | 2.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.5 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 1.8 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 2.9 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.5 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 1.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 4.5 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 4.9 | GO:0060411 | cardiac septum morphogenesis(GO:0060411) |
0.1 | 0.5 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) regulation of cholesterol transporter activity(GO:0060694) pancreatic stellate cell proliferation(GO:0072343) response to metformin(GO:1901558) regulation of pancreatic stellate cell proliferation(GO:2000229) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 0.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 1.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 2.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 13.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 1.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 1.6 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 0.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 6.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 1.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 7.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 1.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 1.8 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 2.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 6.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.7 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.1 | 0.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 1.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 1.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 1.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 2.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 2.7 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.1 | 7.5 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
0.1 | 0.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 2.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 8.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 5.3 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
0.1 | 0.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 1.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 20.1 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.1 | 7.7 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 1.8 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 1.6 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 3.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.6 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 6.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 1.3 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.4 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation by host of symbiont transcription(GO:0052472) |
0.1 | 1.4 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.1 | 0.7 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.1 | 0.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 3.5 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.6 | GO:0098743 | cell aggregation(GO:0098743) |
0.0 | 0.5 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 1.3 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 3.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 1.1 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.0 | 1.2 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.0 | 2.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.8 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 1.1 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 1.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 1.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 1.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 2.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 1.2 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.0 | 1.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.4 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.1 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 2.3 | GO:0030879 | mammary gland development(GO:0030879) |
0.0 | 0.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 1.8 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 1.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.6 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 1.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.2 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 1.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.4 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 1.2 | GO:0007030 | Golgi organization(GO:0007030) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.2 | 272.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
23.7 | 165.7 | GO:0042825 | TAP complex(GO:0042825) |
17.1 | 102.6 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
10.7 | 75.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
8.4 | 25.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
8.0 | 40.2 | GO:0071797 | LUBAC complex(GO:0071797) |
7.2 | 43.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
6.0 | 36.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
4.1 | 36.8 | GO:0030870 | Mre11 complex(GO:0030870) |
3.7 | 58.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
3.6 | 17.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
3.5 | 10.5 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
3.1 | 21.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
3.1 | 59.0 | GO:0033391 | chromatoid body(GO:0033391) |
2.5 | 9.9 | GO:0070985 | TFIIK complex(GO:0070985) |
2.4 | 26.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
2.4 | 50.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
2.4 | 190.5 | GO:0015030 | Cajal body(GO:0015030) |
2.2 | 6.6 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
1.9 | 13.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.7 | 12.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
1.6 | 8.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.4 | 93.4 | GO:0016235 | aggresome(GO:0016235) |
1.3 | 16.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.3 | 5.3 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
1.3 | 3.8 | GO:0097444 | spine apparatus(GO:0097444) |
1.2 | 9.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 8.9 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
1.0 | 19.4 | GO:0032059 | bleb(GO:0032059) |
1.0 | 13.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.9 | 63.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.9 | 6.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.9 | 13.8 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 16.8 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.9 | 30.6 | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.9 | 3.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.8 | 4.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.8 | 13.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.8 | 53.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.8 | 6.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 25.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.7 | 3.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.7 | 4.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 122.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.6 | 67.1 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
0.6 | 14.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 7.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 239.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.6 | 3.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.5 | 1.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.5 | 5.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 13.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 24.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 9.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 88.7 | GO:0031968 | mitochondrial outer membrane(GO:0005741) organelle outer membrane(GO:0031968) |
0.4 | 133.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 1.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 13.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.4 | 3.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.3 | 2.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 2.3 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.0 | GO:0031905 | early endosome lumen(GO:0031905) |
0.3 | 4.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 2.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 676.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 1.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.3 | 2.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 41.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 6.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 31.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.3 | 1.4 | GO:0046930 | membrane attack complex(GO:0005579) pore complex(GO:0046930) |
0.3 | 1.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.3 | 3.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 1.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 8.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 187.3 | GO:0009986 | cell surface(GO:0009986) |
0.3 | 2.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 2.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 8.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 54.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 1.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 2.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 5.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 5.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 6.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 10.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 3.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 15.5 | GO:0035580 | specific granule lumen(GO:0035580) |
0.2 | 12.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 2.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 1.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 24.6 | GO:0005635 | nuclear envelope(GO:0005635) |
0.2 | 59.1 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 97.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 3.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 126.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 1.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 3.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 20.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 2.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 1.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 10.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 37.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 12.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 148.2 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 1.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 3.0 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 2.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.3 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 4.1 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 4.8 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 6.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 2.3 | GO:0005844 | polysome(GO:0005844) |
0.1 | 27.3 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 4.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 1.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 1.1 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 1.9 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 4.5 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 1.1 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.6 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 1.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 2.1 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 1.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 1.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 41.9 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 2.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 97.3 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
53.1 | 159.3 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
32.2 | 354.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
31.2 | 93.5 | GO:0042007 | interleukin-18 binding(GO:0042007) |
29.1 | 116.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
28.6 | 143.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
20.7 | 165.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
13.3 | 106.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
12.2 | 48.8 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
9.8 | 29.5 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
9.2 | 283.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
8.8 | 35.3 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
7.4 | 294.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
6.5 | 25.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
6.4 | 32.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
5.8 | 17.5 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
5.8 | 11.5 | GO:0046979 | TAP2 binding(GO:0046979) |
5.5 | 43.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
5.4 | 43.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
5.3 | 26.4 | GO:0048030 | disaccharide binding(GO:0048030) |
5.3 | 174.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
4.9 | 29.3 | GO:0004882 | androgen receptor activity(GO:0004882) |
4.5 | 36.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
4.1 | 82.1 | GO:0070628 | proteasome binding(GO:0070628) |
4.0 | 88.8 | GO:0032183 | SUMO binding(GO:0032183) |
3.9 | 19.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
3.6 | 32.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
3.3 | 39.9 | GO:0031386 | protein tag(GO:0031386) |
3.0 | 96.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
3.0 | 62.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
2.9 | 17.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
2.8 | 8.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
2.8 | 276.5 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
2.4 | 38.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
2.3 | 23.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.3 | 18.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.2 | 15.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
2.1 | 6.4 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
2.1 | 27.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.9 | 7.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.8 | 5.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.8 | 8.9 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
1.6 | 6.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
1.6 | 34.4 | GO:0051400 | BH domain binding(GO:0051400) |
1.5 | 12.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
1.5 | 4.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.4 | 4.3 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
1.4 | 10.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.4 | 26.4 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.4 | 4.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
1.3 | 36.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.3 | 5.2 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
1.3 | 60.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.3 | 3.8 | GO:0008478 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
1.2 | 8.6 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
1.1 | 102.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
1.1 | 12.9 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
1.0 | 4.0 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
1.0 | 13.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.0 | 2.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.0 | 6.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.0 | 5.7 | GO:0045569 | TRAIL binding(GO:0045569) |
0.9 | 26.4 | GO:0005521 | lamin binding(GO:0005521) |
0.9 | 14.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.9 | 6.5 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.9 | 47.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.9 | 7.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.8 | 45.0 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.8 | 7.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.8 | 4.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.8 | 6.1 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.7 | 2.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.6 | 5.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.6 | 3.0 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.6 | 4.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.6 | 11.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 3.5 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.6 | 8.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 8.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.6 | 3.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 2.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.5 | 5.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 59.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.5 | 32.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.5 | 220.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.5 | 2.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 6.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 2.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 14.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 2.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.5 | 5.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 18.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.4 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 4.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 6.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.4 | 9.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 0.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 19.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 2.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 33.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 2.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 11.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 9.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.4 | 8.5 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.4 | 71.9 | GO:0004386 | helicase activity(GO:0004386) |
0.4 | 5.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 12.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.4 | 2.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 4.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 3.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 7.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 2.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 2.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.3 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.3 | 10.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 57.4 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 2.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 8.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 0.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 5.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 2.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 2.1 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 5.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 5.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 6.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.3 | 4.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 286.5 | GO:0008270 | zinc ion binding(GO:0008270) |
0.3 | 46.8 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.3 | 73.6 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.3 | 1.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 4.8 | GO:0005549 | odorant binding(GO:0005549) |
0.2 | 5.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 1.1 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.2 | 1.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 2.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.7 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 1.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 7.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.8 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 4.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 13.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 11.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.8 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 12.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 6.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 40.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 1.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 5.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 7.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.0 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.2 | 1.0 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.2 | 2.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 5.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.7 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 2.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.2 | 7.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 0.5 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 3.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 17.6 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 2.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 1.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 1.0 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.1 | 4.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 1.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 2.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 3.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 2.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 3.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 12.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 2.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 4.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.3 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.1 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 21.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 1.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 1.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.5 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 0.7 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 2.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 8.0 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 1.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 3.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 2.1 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 2.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 3.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 2.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 2.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 3.6 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 2.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 3.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 2.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 3.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 1.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 1.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.3 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 1.8 | GO:0047555 | cGMP binding(GO:0030553) 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 1.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 3.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.9 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.9 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.1 | 2.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 11.1 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 94.1 | GO:0042802 | identical protein binding(GO:0042802) |
0.1 | 2.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 3.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.2 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 1.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.0 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 2.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 44.0 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 1.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 1.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 3.1 | GO:0005261 | cation channel activity(GO:0005261) |
0.0 | 1.3 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 25.2 | PID IFNG PATHWAY | IFN-gamma pathway |
2.7 | 89.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.3 | 78.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.3 | 56.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.0 | 40.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
2.0 | 38.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.8 | 134.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.7 | 86.4 | PID MYC PATHWAY | C-MYC pathway |
1.2 | 65.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.0 | 58.8 | PID AURORA A PATHWAY | Aurora A signaling |
1.0 | 36.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.8 | 80.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.8 | 26.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.8 | 9.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.8 | 16.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.7 | 110.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.7 | 34.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 31.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 26.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.6 | 10.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.6 | 20.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.6 | 36.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.6 | 34.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 29.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 16.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 69.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 28.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 20.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 11.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 8.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 12.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 8.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 7.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 103.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 1.0 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 7.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 5.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 6.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 2.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 1.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 9.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 2.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 13.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 6.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 29.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 8.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 8.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 3.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 24.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 3.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 4.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 12.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.7 | 1370.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
9.1 | 126.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
5.4 | 16.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
5.0 | 146.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
4.2 | 304.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
3.7 | 107.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
3.4 | 171.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
3.2 | 90.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
2.8 | 25.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
2.8 | 124.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.6 | 39.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
2.5 | 90.8 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
2.5 | 162.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
2.3 | 58.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
2.1 | 78.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.8 | 23.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.0 | 15.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.0 | 13.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.9 | 32.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.9 | 12.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 17.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.6 | 50.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.6 | 137.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 2.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 11.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 9.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 2.8 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.4 | 5.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 10.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 9.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 17.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 8.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 19.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 22.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 7.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 11.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 13.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 6.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 3.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 7.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 4.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 5.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 3.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 6.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 1.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 5.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 3.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 4.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 16.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 3.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 4.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 8.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 2.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 5.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 2.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 2.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 6.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 3.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 2.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 5.8 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 8.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 2.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 4.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 5.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 2.2 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 1.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 1.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 5.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 7.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 1.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 1.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 2.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 2.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 2.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |